Title : The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers.

Pub. Date : 2012 Feb 15

PMID : 21761396






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers. taxane BRCA1 DNA repair associated Homo sapiens
2 BACKGROUND: We assessed the efficacy of taxane chemotherapy in BRCA1- and BRCA2-associated patients compared with sporadic metastatic breast cancer patients. taxane BRCA1 DNA repair associated Homo sapiens
3 CONCLUSIONS: BRCA1-associated, HRec-negative metastatic breast cancer patients were less sensitive to taxane chemotherapy than sporadic HRec-negative patients. taxane BRCA1 DNA repair associated Homo sapiens
4 HRec-positive BRCA1- and BRCA2-associated patients had a sensitivity to taxane chemotherapy similar to that of sporadic patients. taxane BRCA1 DNA repair associated Homo sapiens